Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Emmanuel Chartier-Kastler

Emmanuel J. Chartier-Kastler MD, PhD

Professor and Chief, Division of Urology, Academic Hospital Pitié-Salpétrière (AP-HP), Medical School Sorbonne Université, Paris, France

Dr. Emmanuel Chartier-Kastler is accredited as Professor of Urology at the Department of Urology, at Sorbonne Université, Paris, France, since 2001. He is the current chief of the department and leading the functional urology programme, including female and male urinary incontinence diagnosis and management, female pelvic floor disorder, urological malformations and neurourology.

Dr. Chartier-Kastler received his MD from Paris 6 University in 1989 and was accredited as a urologist in 1992. He is accredited as general surgeon and urologist. He was Fellow and Assistant Professor between 1992 and 1998 in the department of Urology of the academic Pitié-Salpétrière hospital. He is a full professor since 2001.

Dr. Chartier-Kastler is an active member of the board of the French Association of Urology (AFU), past General Secretary (2004-2007) and past Chair of the scientific committee, past member of the AFU Neurourology Committee and an active member of the French speaking group of Neurourology (GENULF). He is involved in the major international congresses of urology as a speaker and/or Chair. He was involved in the French consensus conference regarding urinary nosocomial infections (2004) and was an active member of the committee for conservative treatment in the neuropathic area during the International Consultation on Incontinence (ICI) from 1998 to 2004. He is the current chairman of the ICS NeuroUrology Promotion Committee (2014-2020). He has been member of the organising committee of major international and national meetings, and co-Chaired the 2015 IUGA in France (Nice).

His research interests include the diagnosis and management of incontinence (pharmacological treatments, devices and surgery), overactive bladder (neuromodulation, botulinum toxin studies and other new treatments under development), BPH (new treatments) and neurourology.

Pr. Chartier-Kastler has published over 400 peer-reviewed articles and book chapters on topics related to urology, especially in the field of incontinence and neuro-urology. With Pr. Giuliano (chair) and Pr. Denys , he is leading a public research unit dedicated to neuropharmacology of the bladder and sexual dysfunction.


Dr. Chartier-Kastler is a speaker and/or consultant for Boston Scientific, BBraun, Convatec, Coloplast, Wellspect, Uromedica, Promedon, and Uromems,